Candace L. Haddox, MD

Candace Haddox, MD, sees patients with soft tissue and bone sarcomas and tumors, and also leads clinical trials both in the sarcoma group and in Dana Farber’s early phase clinical trial program. Her research interests are in identifying and developing novel targeted therapies and immune therapies across various subtypes of sarcomas and also fundamentally understanding why treatments do or do not work.